Download PDF
Thromb Haemost 1983; 49(03): 252
DOI: 10.1055/s-0038-1657379
Letter to the Editor
Schattauer GmbH Stuttgart

Differential AT III-Response to Oral and Parenteral Administration of 17 β-Estradiol

J Conard
1   The Laboràtoire Central d’Hèmatologie, Hôtel-Dieu, 75181 Paris Cedex 04, France
,
M Samama
1   The Laboràtoire Central d’Hèmatologie, Hôtel-Dieu, 75181 Paris Cedex 04, France
,
A Basdevant
2   Clinique Mèdicale, Hôtel-Dieu, 75181 Paris Cedex 04, France
,
B Guy-Grand
2   Clinique Mèdicale, Hôtel-Dieu, 75181 Paris Cedex 04, France
,
B de Lignières
3   The Service d’Endocrinologie, Hôpital Necker, 75730 Paris Cedex 15, France
› Author Affiliations
Further Information

Publication History

Received 28 March 1983

Accepted 25 April 1983

Publication Date:
18 July 2018 (online)

Also available at
  PDF Download  Permissions and Reprints
 

  • References

  • 1 Conard J, Cazenave B, Samama M, Horellou MH. AT HI content and antithrombin activity in oestrogen-progestogen and progestogen only treated women. Thromb Res 1980; 18: 675-683
    CrossrefPubMedGoogle Scholar
  • 2 Whitehead MI, Townsend PT, Kuchin Y, Dyer G, Iobal MJ, Mansfield MD, Young O, Minardi J. Plasma steroid and protein hormone profiles in postmenopausal women following topical administration of oestradiol 17 β. In Mauvais-Jarvis P, Vickers CF, Wepierre J. (Ed). Percutaneous absorption of steroids. Academic Press; London: 1980. pp. 231-248
    Google Scholar
  • 3 von Kaulla E, von Kaulla K. Antithrombin III and diseases. Am J Clin Pathol 1967; 48: 69-80
    CrossrefPubMedGoogle Scholar
  • 4 Gjonnaess H, Munkeby I, Frolich W, Vennerod AM, Fagerhol M. Effect of estrogen treatment on coagulation and fibrinolysis in postmenopausal women. Gynecol Obstet Invest 1978; 9: 109-123
    CrossrefPubMedGoogle Scholar
  • 5 Elkik F, Gompel A, Merderbodard C, Kuttenn F, Guyenne PN, Corvol P, Mauvais-Jarvis P. Effects of percutaneous estradiol and conjugated estrogens on the level of plasma proteins and triglycerides in postmenopausal women. Am J Obstet Gynecol 1981; 143: 888-890
    PubMedGoogle Scholar
  • 6 Fenichel P, Balarac N, Isetta M, Melandri E, Tran DK, Bayle J, Gillet JY. Effet d’une association estradiol percutane-progesterone micronis•e orale sur I’hemostase en p•riode de pirimenopause. Rev Franc Gynecol Obstet 1982; 77: 93-97
    PubMedGoogle Scholar
  • 7 Mishcll DR, Moore DE, Roy S, Brenner PF, Page MA. Clinical performance and endocrine profiles with contraceptive vaginal rings containing a combination of estradiol and dnorgestrel. Am J Obstet Gynecol 1978; 130: 55-62
    CrossrefPubMedGoogle Scholar
  • 8 Astedt B, Jeppsson S. 17 β-oestradiol and the fibrinolytic activity of vein walls. J Obstet Gynaecol Brit Common 1974; 81: 719-723
    PubMedGoogle Scholar
  • 9 Davies T, Ficldhouse G, Me Nicol GP. The effects of therapy with oestriol succinate and ethinyl oestradiol on the haemostatic mechanism in postmenopausal women. Thromb Haemostas 1976; 35: 403-414
    PubMedGoogle Scholar
  • 10 Lagretius A, Lunell NO, Blomback M. Natural oestrogen in the female climacteric. Influence on blood coagulation and fibrinolysis. Thromb Haemostas 1978; 40: 532-541
    PubMedGoogle Scholar
  • 11 Hunter DJ S, Anderson ABM, Haddon M. Changes in coagulation factors in postmenopausal women on ethinyl estradiol. Br J Obstet Gynaecol 1979; 86: 488-490
    CrossrefPubMedGoogle Scholar